Home » Newsletters » BioWorld Science

BioWorld Science

May 11, 2022

View Archived Issues

SIGLEC15 promotes immune system evasion in lymphoma

TL-532 induces life-long antitumor autovaccination and cross-immunity against unrelated cancers

Rheinische Friederich-Wilhelms-Universitaet Bonn discloses MRGPRX4 agonists

Chinese researchers describe new ADCs for cancer

Proxygen and collaborators present new compounds for cancer

AC Immune synthesizes MAPT aggregation inhibitors

Accent Therapeutics discloses METTL3 inhibitors

Targeting BCL10-MALT1 interaction blocks ABC-DLBCL xenograft tumor growth

Type 2 diabetes getting precision medicine makeover

MALT1 promotes glioblastoma pathogenesis and emerges as a potential therapeutic target

Celsion advances PLACCINE DNA-based vaccine platform to proof-of-concept NHP studies

NexImmune, Yale and JDRF partner to explore AIM nanoparticles with teplizumab for type 1 diabetes

NodThera announces addition of third NLRP3 inflammasome inhibitor to pipeline

Incannex's IHL-216A shows neuroprotective effect in rodent model of sports concussion

Galectin-8 as a novel target for the treatment of bacterial keratitis

Investigators present new murine model of Kcnv2-mutated CDSRR

Long noncoding RNA LOC100506453 found as useful for treatment monitoring in APL

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...